Written by
Mustafa Çelik
Mustafa Çelik Liv Hospital Content Team
Medically reviewed by

Related Doctors

Assoc. Prof. MD. Evrim Duman Liv Hospital Ulus Assoc. Prof. MD. Evrim Duman Radiation Oncology Asst. Prof. MD. Meltem Topalgökçeli Selam Liv Hospital Ulus Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology Prof. MD. Duygu Derin Liv Hospital Ulus Prof. MD. Duygu Derin Medical Oncology Prof. MD. Emre Merdan Fayda Liv Hospital Ulus Prof. MD. Emre Merdan Fayda Radiation Oncology Prof. MD. Meral Günaldı Liv Hospital Ulus Prof. MD. Meral Günaldı Medical Oncology Assoc. Prof. MD. Murat Ayhan Liv Hospital Vadistanbul Assoc. Prof. MD. Murat Ayhan Medical Oncology Prof. MD.  Itır Şirinoğlu Demiriz Liv Hospital Vadistanbul Prof. MD. Itır Şirinoğlu Demiriz Hematology Prof. MD. Tülin Tıraje Celkan Liv Hospital Vadistanbul Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology Assoc. Prof. MD. Erkan Kayıkçıoğlu Liv Hospital Bahçeşehir Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology Assoc. Prof. MD. Mine Dağgez Liv Hospital Bahçeşehir Assoc. Prof. MD. Mine Dağgez Gynecological Oncology Assoc. Prof. MD. Ozan Balakan Liv Hospital Bahçeşehir Assoc. Prof. MD. Ozan Balakan Medical Oncology MD. Taylan Bükülmez Liv Hospital Bahçeşehir MD. Taylan Bükülmez Radiation Oncology Op. MD. Alp Koray Kinter Liv Hospital Bahçeşehir Op. MD. Alp Koray Kinter Gynecological Oncology Prof. MD. Nuri Faruk Aykan Liv Hospital Bahçeşehir Prof. MD. Nuri Faruk Aykan Medical Oncology Prof. MD. Yasemin Altuner Torun Liv Hospital Bahçeşehir Prof. MD. Yasemin Altuner Torun Pediatric Hematology and Oncology Spec. MD. Özlem Doğan Liv Hospital Bahçeşehir Spec. MD. Özlem Doğan Medical Oncology Assoc. Prof. MD. Emir Çelik Liv Hospital Topkapı Assoc. Prof. MD. Emir Çelik Medical Oncology Assoc. Prof. MD. Muhammed Mustafa Atcı Liv Hospital Topkapı Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology Prof. MD. İrfan Çiçin Liv Hospital Topkapı Prof. MD. İrfan Çiçin Medical Oncology Assoc. Prof. MD.  Ramazan Öcal Liv Hospital Ankara Assoc. Prof. MD. Ramazan Öcal Hematology Assoc. Prof. MD. Nazlı Topfedaisi Özkan Liv Hospital Ankara Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology Prof. MD. Fikret Arpacı Liv Hospital Ankara Prof. MD. Fikret Arpacı Medical Oncology Prof. MD. Gökhan Erdem Liv Hospital Ankara Prof. MD. Gökhan Erdem Medical Oncology Prof. MD. Meral Beksaç Liv Hospital Ankara Prof. MD. Meral Beksaç Hematology Prof. MD. Oral Nevruz Liv Hospital Ankara Prof. MD. Oral Nevruz Hematology Prof. MD. Saadettin Kılıçkap Liv Hospital Ankara Prof. MD. Saadettin Kılıçkap Medical Oncology Prof. MD. Sadık Muallaoğlu Liv Hospital Ankara Prof. MD. Sadık Muallaoğlu Medical Oncology Spec. MD. Ender Kalacı Liv Hospital Ankara Spec. MD. Ender Kalacı Medical Oncology Assoc. Prof. MD. Fadime Ersoy Dursun Liv Hospital Gaziantep Assoc. Prof. MD. Fadime Ersoy Dursun Hematology Prof. MD. Fatih Teker Liv Hospital Gaziantep Prof. MD. Fatih Teker Medical Oncology Spec. MD. ELXAN MEMMEDOV Liv Bona Dea Hospital Bakü Spec. MD. ELXAN MEMMEDOV Medical Oncology Spec. MD. Ceyda Aslan Spec. MD. Ceyda Aslan Hematology Spec. MD. Elkhan Mammadov Spec. MD. Elkhan Mammadov Medical Oncology Spec. MD. Elmir İsrafilov Spec. MD. Elmir İsrafilov Hematology Spec. MD. Minure Abışova Eliyeva Spec. MD. Minure Abışova Eliyeva Hematology Spec. MD. Natavan Azizova Spec. MD. Natavan Azizova Medical Oncology Prof. MD. Mehmet Hilmi Doğu Liv Hospital Ulus + Liv Hospital Bahçeşehir Prof. MD. Mehmet Hilmi Doğu Hematology
...
Views
Read Time
...
views
Read Time

Drug Overview

8 hydroxyquinoline sulfate ointment sulfate ointment is an important supportive care medicine used in oncology. While it does not treat cancer itself, it plays a vital role in protecting a patient’s skin and preventing infections during cancer treatments.

  • Generic Name: 8-hydroxyquinoline sulfate ointment
  • US Brand Names: Available under various over-the-counter (OTC) brand names (such as certain formulations of Bag Balm) or mixed specifically by a compounding pharmacy.
  • Drug Class: Topical Antiseptic, Metal Chelator, and Skin Protectant.
  • Route of Administration: Topical (applied directly to the skin).
  • FDA Approval Status: Approved as an Over-The-Counter (OTC) and compounded topical first-aid ingredient for skin protection and antiseptic use.

What Is It and How Does It Work? (Mechanism of Action)

8 hydroxyquinoline sulfate ointment
8 hydroxyquinoline sulfate ointment 2

8-hydroxyquinoline sulfate ointment contains two main parts: an active germ-fighting medicine (8-hydroxyquinoline sulfate) and a moisturizing, protective base (usually containing petrolatum and lanolin).

At the molecular level, this drug is highly advanced in how it targets microbes:

  • Metal Chelation (Starving the Pathogen): 8-hydroxyquinoline (8HQ) acts as a strong “metal chelator.” Bacteria and fungi rely heavily on specific trace metals—like iron, zinc, and copper—to power their internal enzymes (metalloenzymes). For example, they need these metals to make ribonucleotide reductase, an enzyme required to copy their DNA. 8HQ tightly binds to these metals in the environment, starving the germs of the fuel they need to grow and multiply.
  • Copper Ionophore (The Trojan Horse Effect): 8HQ does more than just steal metals; it acts as an “ionophore.” It binds to copper to form a fat-soluble package that easily slips through the outer walls of bacteria and fungi. Once inside the germ, the copper is released, causing severe oxidative stress. This generates reactive oxygen species (ROS) that tear apart the germ’s DNA, leading to rapid cell death.
  • Skin Barrier Protection: While the active drug kills the germs, the lanolin and petrolatum base creates a physical, waterproof shield over the patient’s skin. This prevents transepidermal water loss (keeping the skin hydrated) and blocks new environmental germs from entering fragile areas.

FDA Approved Clinical Indications

  • Oncological Uses (Supportive Care):
    • Prevention of secondary bacterial or fungal infections in skin compromised by radiation therapy (radiation dermatitis).
    • Wound care and protection for minor surgical incisions or biopsy sites.
    • Soothing and protecting chafed, excessively dry skin caused by certain chemotherapy agents.
  • Non-Oncological Uses:
    • First-aid antiseptic for minor cuts, scrapes, and superficial burns.
    • Treatment of mild, localized dermatological fungal or bacterial infections.
    • Moisturizing and sealing severely chapped skin.

Dosage and Administration Protocols

Because this medicine is applied externally, dosing is straightforward.

Administration RouteStandard DoseFrequencyInfusion Time
Topical (Skin)Apply a thin, even layer to the affected area1 to 3 times a dayN/A (Ointment)

Dose Adjustments

  • Renal (Kidney) or Hepatic (Liver) Insufficiency: Because this medication is applied to the skin, systemic absorption (the amount that enters the bloodstream) is extremely low. Therefore, no dose adjustments are required for patients with poor kidney or liver function.

Clinical Efficacy and Research Results

While large-scale cancer survival data does not apply to this skin ointment, current microbiological research (2020–2025) demonstrates its powerful supportive benefits:

  • Potent Antimicrobial Action: Recent laboratory studies show that the minimum inhibitory concentration (MIC) the lowest amount of drug needed to stop germ growth for 8-hydroxyquinoline is comparable to standard prescription antibiotics like ampicillin.
  • Controlling Resistant Pathogens: Data shows that 8HQ is highly effective against resistant Gram-positive bacteria (like Staphylococcus aureus) and common fungal threats (like Candida albicans). It successfully disrupts the “biofilms” (protective slime shields) these germs use to hide from standard drugs.
  • Impact on Disease Progression: By efficiently preventing severe skin infections and wound breakdowns, this ointment helps prevent treatment delays. Keeping the skin healthy ensures patients do not have to pause their life-saving radiation or chemotherapy sessions.

Safety Profile and Side Effects

As a topical treatment, 8-hydroxyquinoline sulfate ointment is generally very safe and well-tolerated.

Common Side Effects (>10%)

  • Application Site Irritation: Mild, temporary stinging or burning immediately after putting the ointment on broken skin.
  • Mild Erythema: Slight redness or pinkness of the skin around the treated area.

Serious Adverse Events

  • Contact Dermatitis: An allergic skin reaction characterized by intense itching, severe swelling, or the formation of blisters.
  • Systemic Toxicity (Extremely Rare): If a patient applies massive amounts of the ointment over very large, deep, open wounds for a long time, trace amounts could enter the blood. Historically, massive internal doses of quinolines have caused neurotoxicity, but this is virtually impossible with standard topical use.

Black Box Warning

  • There is no FDA Black Box Warning for this medication.

Management Strategies

  • If you experience severe itching, blistering, or a rash that spreads beyond the application site, wipe the ointment off and wash the area gently with mild soap and water.
  • Discontinue use and contact your healthcare provider, who may recommend a mild topical steroid (like hydrocortisone cream) to calm the allergic reaction.

Connection to Stem Cell and Regenerative Medicine

While the ointment is a traditional wound care product, its active ingredient 8-hydroxyquinoline is at the forefront of modern regenerative medicine and oncology research. For advanced stem cell-derived skin grafts to successfully attach to a patient’s body, the wound bed must be completely free of bacterial biofilms. The powerful anti-biofilm properties of 8-hydroxyquinoline make it an excellent agent for preparing surgical beds for regenerative therapies. Furthermore, scientists are currently investigating if the copper-targeting mechanisms of the 8HQ family can be developed into an internal Targeted Therapy to hunt down and selectively destroy cancer stem cells without harming healthy tissue.

Patient Management and Practical Recommendations

Pre-Treatment Tests

  • Patch Test: Your doctor may advise applying a tiny amount of the ointment to your forearm for 24 hours to ensure you are not allergic to the active drug or the lanolin base.
  • Wound Swab: If a skin area is severely infected, the medical team might take a culture swab to confirm exactly which bacteria is present before starting treatment.

Precautions During Treatment

  • Avoid Sensitive Areas: Do not put this ointment inside the eyes, nose, or mouth.
  • Wound Depth: Do not use this product on deep puncture wounds, animal bites, or severe, weeping burns unless explicitly directed by an oncologist or wound care specialist.

Do’s and Don’ts

  • DO clean and gently pat the skin completely dry before applying the ointment.
  • DO apply only a light, thin layer. Applying thick, heavy amounts does not make it heal the skin faster.
  • DON’T cover the treated area with tight, unbreathable bandages (occlusive dressings) unless your doctor tells you to do so, as this can trap too much moisture.
  • DON’T share your tube of ointment with other people, as this can spread infections.

Legal Disclaimer

The information provided in this guide is for educational and informational purposes only and does not constitute medical advice. 8-hydroxyquinoline sulfate ointment is a supportive care medication used for skin protection and is not a treatment or cure for cancer. Always consult with a qualified healthcare professional, your wound care specialist, or your primary oncologist regarding any medical conditions, treatment options, or product usage. Do not disregard professional medical advice or delay seeking it because of something you have read here.

i

Medical Disclaimer

The content on this page is for informational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Always consult a qualified healthcare provider regarding any medical conditions.

Book a Free Certified Online
Doctor Consultation

Clinics/branches
GDPR

We're Here to Help.
Get in Touch

Send us all your questions or requests, and our
expert team will assist you.

Our Doctors

Assoc. Prof. MD. Evrim Duman Radiation Oncology

Assoc. Prof. MD. Evrim Duman

Liv Hospital Ulus
Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology

Asst. Prof. MD. Meltem Topalgökçeli Selam

Liv Hospital Ulus
Prof. MD. Duygu Derin Medical Oncology

Prof. MD. Duygu Derin

Liv Hospital Ulus
Prof. MD. Emre Merdan Fayda Radiation Oncology

Prof. MD. Emre Merdan Fayda

Liv Hospital Ulus
Prof. MD. Mehmet Hilmi Doğu Hematology

Prof. MD. Mehmet Hilmi Doğu

Liv Hospital Ulus
Liv Hospital Bahçeşehir
Prof. MD. Meral Günaldı Medical Oncology

Prof. MD. Meral Günaldı

Liv Hospital Ulus
Assoc. Prof. MD. Murat Ayhan Medical Oncology

Assoc. Prof. MD. Murat Ayhan

Liv Hospital Vadistanbul
Prof. MD.  Itır Şirinoğlu Demiriz Hematology

Prof. MD. Itır Şirinoğlu Demiriz

Liv Hospital Vadistanbul
Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology

Prof. MD. Tülin Tıraje Celkan

Liv Hospital Vadistanbul
Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology

Assoc. Prof. MD. Erkan Kayıkçıoğlu

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Mine Dağgez Gynecological Oncology

Assoc. Prof. MD. Mine Dağgez

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Ozan Balakan Medical Oncology

Assoc. Prof. MD. Ozan Balakan

Liv Hospital Bahçeşehir
MD. Taylan Bükülmez Radiation Oncology

MD. Taylan Bükülmez

Liv Hospital Bahçeşehir
Op. MD. Alp Koray Kinter Gynecological Oncology

Op. MD. Alp Koray Kinter

Liv Hospital Bahçeşehir
Prof. MD. Nuri Faruk Aykan Medical Oncology

Prof. MD. Nuri Faruk Aykan

Liv Hospital Bahçeşehir
Prof. MD. Yasemin Altuner Torun Pediatric Hematology and Oncology

Prof. MD. Yasemin Altuner Torun

Liv Hospital Bahçeşehir
Spec. MD. Özlem Doğan Medical Oncology

Spec. MD. Özlem Doğan

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Emir Çelik Medical Oncology

Assoc. Prof. MD. Emir Çelik

Liv Hospital Topkapı
Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology

Assoc. Prof. MD. Muhammed Mustafa Atcı

Liv Hospital Topkapı
Prof. MD. İrfan Çiçin Medical Oncology

Prof. MD. İrfan Çiçin

Liv Hospital Topkapı
Assoc. Prof. MD.  Ramazan Öcal Hematology

Assoc. Prof. MD. Ramazan Öcal

Liv Hospital Ankara
Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology

Assoc. Prof. MD. Nazlı Topfedaisi Özkan

Liv Hospital Ankara
Prof. MD. Fikret Arpacı Medical Oncology

Prof. MD. Fikret Arpacı

Liv Hospital Ankara
Prof. MD. Gökhan Erdem Medical Oncology

Prof. MD. Gökhan Erdem

Liv Hospital Ankara
Prof. MD. Meral Beksaç Hematology

Prof. MD. Meral Beksaç

Liv Hospital Ankara
Prof. MD. Oral Nevruz Hematology

Prof. MD. Oral Nevruz

Liv Hospital Ankara
Prof. MD. Saadettin Kılıçkap Medical Oncology

Prof. MD. Saadettin Kılıçkap

Liv Hospital Ankara
Prof. MD. Sadık Muallaoğlu Medical Oncology

Prof. MD. Sadık Muallaoğlu

Liv Hospital Ankara
Spec. MD. Ender Kalacı Medical Oncology

Spec. MD. Ender Kalacı

Liv Hospital Ankara
Assoc. Prof. MD. Fadime Ersoy Dursun Hematology

Assoc. Prof. MD. Fadime Ersoy Dursun

Liv Hospital Gaziantep
Prof. MD. Fatih Teker Medical Oncology

Prof. MD. Fatih Teker

Liv Hospital Gaziantep
Spec. MD. ELXAN MEMMEDOV Medical Oncology

Spec. MD. ELXAN MEMMEDOV

Liv Bona Dea Hospital Bakü
Spec. MD. Ceyda Aslan Hematology

Spec. MD. Ceyda Aslan

Spec. MD. Elkhan Mammadov Medical Oncology

Spec. MD. Elkhan Mammadov

Spec. MD. Elmir İsrafilov Hematology

Spec. MD. Elmir İsrafilov

Spec. MD. Minure Abışova Eliyeva Hematology

Spec. MD. Minure Abışova Eliyeva

Spec. MD. Natavan Azizova Medical Oncology

Spec. MD. Natavan Azizova

Need Help? Chat with our medical team

Let's Talk on WhatsApp

📌

Get instant answers from our medical team. No forms, no waiting — just tap below to start chatting now.

or call us at +90 530 174 42 01